GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotechnology Assets SA (XMAD:BST) » Definitions » FCF Yield %

Biotechnology Assets (XMAD:BST) FCF Yield % : -1.40 (As of May. 12, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Biotechnology Assets FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Biotechnology Assets's Trailing 12-Month Free Cash Flow is €-0.28 Mil, and Market Cap is €19.89 Mil. Therefore, Biotechnology Assets's FCF Yield % for today is -1.40%.

The historical rank and industry rank for Biotechnology Assets's FCF Yield % or its related term are showing as below:

XMAD:BST' s FCF Yield % Range Over the Past 10 Years
Min: -180.81   Med: -9.67   Max: 46.79
Current: -1.4


During the past 13 years, the highest FCF Yield % of Biotechnology Assets was 46.79%. The lowest was -180.81%. And the median was -9.67%.

XMAD:BST's FCF Yield % is ranked better than
80.85% of 1556 companies
in the Biotechnology industry
Industry Median: -14.17 vs XMAD:BST: -1.40

Biotechnology Assets's FCF Margin % for the quarter that ended in Dec. 2023 was 40.17%.


Biotechnology Assets FCF Yield % Historical Data

The historical data trend for Biotechnology Assets's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotechnology Assets FCF Yield % Chart

Biotechnology Assets Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.34 38.63 -10.33 -17.10 -1.22

Biotechnology Assets Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.67 -31.02 -11.37 -9.85 7.63

Competitive Comparison of Biotechnology Assets's FCF Yield %

For the Biotechnology subindustry, Biotechnology Assets's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotechnology Assets's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotechnology Assets's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Biotechnology Assets's FCF Yield % falls into.



Biotechnology Assets FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Biotechnology Assets's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.278 / 22.8593376
=-1.22%

Biotechnology Assets's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.872 * 2 / 22.8593376
=7.63%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotechnology Assets FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Biotechnology Assets FCF Yield % Related Terms

Thank you for viewing the detailed overview of Biotechnology Assets's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotechnology Assets (XMAD:BST) Business Description

Traded in Other Exchanges
N/A
Address
Avenida del Desarrollo Tecnologico, No. 11, Scientific and Technological Park, Jerez de la Frontera, ESP, 11591
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.